RecruitingNCT02012699

Integrated Cancer Repository for Cancer Research

Sponsor

University of Nebraska

Enrollment

999,999 participants

Start Date

Nov 1, 2013

Study Type

OBSERVATIONAL

Conditions

Summary

The iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal data and biospecimens on consented adult cancer patients, high-risk individuals, and normal controls. The distinct characteristic of the iCaRe2 is its geographical coverage, with a significant percentage of small and rural hospitals and cancer centers. The iCaRe2 advances comprehensive studies of risk factors of cancer development and progression and enables the design of novel strategies for prevention, screening, early detection and personalized treatment of cancer. Centers with expertise in cancer epidemiology, genetics, biology, early detection, and patient care can collaborate by using the iCaRe2 as a platform for cohort and population studies.

Eligibility

Min Age: 19 YearsMax Age: 110 Years

Plain Language Summary

Simplified for easier understanding

This study is creating a large bank of cancer tissue, blood, and related health information from many different types of cancer patients to help researchers across multiple institutions discover new insights, test new ideas, and develop better treatments. **You may be eligible if...** - You have been diagnosed with any type of cancer - You are receiving care at a participating cancer center or hospital - You are willing to allow some of your tissue (from a biopsy or surgery) and blood to be stored for future research - You are at least 18 years old and can give informed consent **You may NOT be eligible if...** - You are unwilling to provide consent for sample collection and storage - Insufficient tissue is available from your procedure for both your clinical care and the research bank - You are being treated at a facility not participating in this repository Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(45)

Advent Health

Greenwood Village, Colorado, United States

Prospect Medical Hospital

Manchester, Connecticut, United States

Florida Hospital Memorial Medical Center

Daytona Beach, Florida, United States

Florida Hospital DeLand

DeLand, Florida, United States

Florida Hospital FISH

Orange City, Florida, United States

Florida Hospital Flagler

Palm Coast, Florida, United States

Tallahassee Memorial Hospital

Tallahassee, Florida, United States

Rush-Copley Cancer Care Center

Aurora, Illinois, United States

Rush-Copley Healthcare Center

Yorkville, Illinois, United States

Parkview Research Center

Fort Wayne, Indiana, United States

Methodist Jennie Edmundson Hospital

Council Bluffs, Iowa, United States

Covenant Medical Center, Inc

Waterloo, Iowa, United States

Saint Luke's Cancer Instititute - South

Overland Park, Kansas, United States

Northwest Hospital

Randallstown, Maryland, United States

William E. Kahlert Regional Cancer Center

Westminster, Maryland, United States

Holyoke Medical Center

Holyoke, Massachusetts, United States

University of Michigan Health System

Ann Arbor, Michigan, United States

Riverwood Healthcare Center

Aitkin, Minnesota, United States

Essentia Health-St. Joseph's Medical Center

Brainerd, Minnesota, United States

Essentia Health - Duluth Clinic

Duluth, Minnesota, United States

St. Luke's Hospital of Duluth

Duluth, Minnesota, United States

Lake Region Healthcare

Fergus Falls, Minnesota, United States

Saint Luke's Cancer Institute, East

Kansas City, Missouri, United States

Saint Luke's Cancer Institute

Kansas City, Missouri, United States

Saint Luke's Cancer Institute, Kansas City North

Kansas City, Missouri, United States

Saint Luke's Cancer Institute, Liberty

Liberty, Missouri, United States

North Kansas City Hospital

North Kansas City, Missouri, United States

Heartland Regional Medical Center dba Mosaic Life Care

Saint Joseph, Missouri, United States

Bozeman Health Deaconess Hospital

Bozeman, Montana, United States

Mary Lanning Healthcare, Morrison Cancer Center

Hastings, Nebraska, United States

Faith Regional Health Services, Carson Cancer Center

Norfolk, Nebraska, United States

Great Plains Regional Medical Center

North Platte, Nebraska, United States

Methodist Estabrook Cancer Center

Omaha, Nebraska, United States

Nebraska Methodist Health System

Omaha, Nebraska, United States

University of Nebraska Medical Center

Omaha, Nebraska, United States

C.R. Wood Cancer Center, Glens Falls Hospital

Glens Falls, New York, United States

Faxton St. Luke's Healthcare, Mohawk Valley

Utica, New York, United States

Cape Fear Valley Health System

Fayetteville, North Carolina, United States

Essentia Health

Fargo, North Dakota, United States

Trinity Hospital Cancer Care Center

Minot, North Dakota, United States

Aultman Alliance Community Hospital

Alliance, Ohio, United States

Aultman Hospital

Canton, Ohio, United States

University of Pittsburgh

Pittsburgh, Pennsylvania, United States

Rutland Regional Medical Center

Rutland, Vermont, United States

Bellin Memorial Hospital

Green Bay, Wisconsin, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02012699

Related Trials

Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome

NCT044310241 location

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

NCT0621891418 locations

Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System

NCT068073593 locations

DESTINY-PANTUMOUR04

NCT0712400017 locations

A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs

NCT0733644618 locations